Rachel Wilson-Cannon
Originally from Canada, Rachel holds an Honours BSc in Biochemistry from the University of Ottawa and brings over a decade of experience in international business development. Her career began in the broader healthcare space, but she quickly gravitated toward the cannabis industry, where she has spent the past six years helping to shape its global trajectory.
Rachel first encountered SOMAÍ during the company’s Australian launch, where the innovation behind the Mint oral solutions caught her attention. Inspired by the company’s science-driven approach and commitment to patient care, she later made the move to Lisbon to join the team.
In her role as Director of Emerging Markets, Rachel is responsible for identifying and building strategic partnerships that expand SOMAÍ’s global footprint. She works closely with distributors, healthcare providers, and regulators across multiple regions to ensure patients have access to innovative and consistent medical cannabis therapies. With a proven track record of launching successful products and forging impactful collaborations, she is uniquely positioned to strengthen SOMAÍ’s presence in both established and emerging markets.
Rachel’s passion lies in bridging science, business, and patient needs. She is dedicated to ensuring that SOMAÍ’s advanced formulations reach patients worldwide, helping to normalize medical cannabis as a trusted therapeutic option. Her energy and expertise embody SOMAÍ’s mission to create a healthier future through natural cannabis-based medicine.